23 The results clearly favored Zepbound
If youre looking for a medically supervised, personalized solution designed for long-term success, you may be an excellent candidate for this program
Based on the promising preclinical data, Bunce conducted a small, double-blind, placebo-controlled trial funded by the National Institute on Drug Abuse and Novo Nordisk, the company that makes Ozempic and Wegovy
FDA drug labeling, Mounjaro (tirzepatide) prescribing information California Medi-Cal excluded weight-loss GLP-1s (Wegovy, Zepbound, Saxenda) effective January 1, 2026 Mounjaro's diabetes coverage is unaffected
Novo CagriSema (cagrilintide + semaglutide) In REDEFINE-4 (84 weeks), CagriSema 2.4/2.4 mg delivered: 23.0% weight loss (efficacy estimand) 20.2% (treatment-regimen estimand) Missed non-inferiority vs tirzepatide Takeaway: Clinically strong, but not a category reset
PlexusDx compounded tirzepatide injection is prepared by licensed 503A compounding pharmacies and is $289/mo month-to-month, or from $249/mo on the 6-month plan across all commitment tiers